Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

BACKGROUND: This phase II study was designed to evaluate the activity and safety of a combination of epirubicin, oxaliplatin and docetaxel in metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. METHODS: Forty patients with measurable distant metastases received epirubicin 50 mg/m(2...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Di Lauro, Luigi, Giacinti, Laura, Arena, Maria Grazia, Sergi, Domenico, Fattoruso, Silvia Ileana, Giannarelli, Diana, Lopez, Massimo
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2009
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2657908/
https://ncbi.nlm.nih.gov/pubmed/19267943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-28-34
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker